Who owns TXG?
Institutional ownership of 10x Genomics Inc. from Form 13F, Q2 2026
391 institutional managers reported holding 10x Genomics Inc. (TXG) in Form 13F filings for Q2 2026, with 128,574,617 shares worth $4.9B. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 3,667,875 shares (+2.9%). 98 opened new positions and 34 sold out.
- Funds holding
- 391
- Value held
- $4.9B
- New / sold out
- 98 / 34
- Net shares, same filers
- +2.9%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of TXG
Share of 13F holdings is each fund's shares as a share of the 128,574,617 TXG shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Price T Rowe Associates Inc Added+$168M
- Citadel Advisors LLC Added+$78.0M
- Point72 Asset Management, L.P. New+$71.0M
- Anomaly Capital Management, LP New+$33.3M
- Jane Street Group, LLC New+$28.9M
- BlackRock, Inc. Added+$27.8M
- Morgan Stanley Added+$26.7M
- Clough Capital Partners L P New+$21.1M
- Samlyn Capital, LLC New+$19.3M
- Nuveen, LLC Added+$19.1M
Biggest sellers in Q2 2026
- Millennium Management LLC Trimmed-$74.8M
- ARK Investment Management LLC Trimmed-$65.7M
- Casdin Capital, LLC Trimmed-$47.0M
- Sumitomo Mitsui Trust Group, Inc. Trimmed-$35.1M
- Amova Asset Management Americas, Inc. Trimmed-$35.0M
- Goldman Sachs Group Inc Trimmed-$31.6M
- Balyasny Asset Management L.P. Sold out-$21.0M
- AQR Capital Management LLC Trimmed-$18.9M
- Blue Water Life Science Advisors, LP Trimmed-$17.2M
- Federated Hermes, Inc. Trimmed-$13.9M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $745M and sold $552M; 97 added and 139 trimmed.
Schedule 13D and 13G filings on TXG
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-09-08PRICE T ROWE ASSOCIATES INC /MD/ SCHEDULE 13G filed by 10x Genomics Inc.Schedule 13G
- 2025-08-13Nikko Asset Management Americas, Inc. SCHEDULE 13G filed by 10x Genomics Inc.Schedule 13G
- 2025-07-31Sumitomo Mitsui Trust Group, Inc. SCHEDULE 13G filed by 10x Genomics Inc.Schedule 13G
- 2025-04-04MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by 10x Genomics Inc.Schedule 13G
Questions about TXG ownership
- Who owns TXG stock?
- 391 institutional investment managers reported TXG positions in their Form 13F filings for Q2 2026, holding 128,574,617 shares worth $4.9B in total. FMR LLC reported the largest position.
- Are funds buying or selling TXG?
- In Q2 2026, 98 managers opened new TXG positions, 97 added, 139 trimmed and 34 sold out. Managers that filed in both quarters added a net 3,667,875 shares.
- How current is this TXG institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to TXG by CUSIP. Options are left out. TXG news and filings · TXG insider trades · Top funds